Clinical Trial Update: Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pyrimethamine plus sulfadiazine versus spiramycin for preventing congenital toxoplasmosis during pregnancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Toxoplasmosis

Drugs mentioned

• Pyrimethamine (Pyrimethamine)
• Spiramycin (spiramycin)
• Sulfadiazine (Sulfadiazine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Congenital Toxoplasmosis | Phase 3 | Status: COMPLETED